Entity
AstraZeneca
AstraZeneca is a British-Swedish multinational pharmaceutical company that researches, develops, and manufactures prescription medicines for major diseases like cancer, cardiovascular, and respiratory conditions.
Why it’s in the news: It is in the news for making multi-billion dollar investments in biotech partnerships and for its drugs being approved for coverage in national healthcare systems.
Latest on AstraZeneca
- STAT+: AstraZeneca opens new Boston site
- STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more
- Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca
- STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
- AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows
- AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs
- celebrating a $1 billion investment in the unsettled center of U.S. biotechnology
- AstraZeneca opened a new R&D site in Kendall Square yesterday
- 13F: Parrish Capital Llc holds Astrazeneca ($2M)
Connections
27 entities linked to AstraZeneca across the news graph.
Also connected to (27)
Parrish Capital LlcSTAT+: AstraZeneca opens new Boston siteHealth Care Roundup: Market TalkHong Kong needs new funding model to draw investment from global drug makers: AstraZenecaHealth Care Roundup: Market TalkSTAT+: AstraZeneca invests $2 billion in Summit TherapeuticsHealth Care Roundup: Market TalkKendall SquareU.S. biotechnologyHong KongSECChineseNovoMerckWainuaAlnylamSTATIonisWePharmalittleChinaImfinziAkesoBristol Myers Squibb